0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Bulk Drug Intermediates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-39H8637
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bulk Drug Intermediates Market Outlook 2022
BUY CHAPTERS

Bulk Drug Intermediates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39H8637
Report
November 2024
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bulk Drug Intermediates - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bulk Drug Intermediates - Market

Bulk Drug Intermediates - Market

The global market for Bulk Drug Intermediates was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bulk Drug Intermediates, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bulk Drug Intermediates by region & country, by Type, and by Application.
The Bulk Drug Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bulk Drug Intermediates.
Market Segmentation

Scope of Bulk Drug Intermediates - Market Report

Report Metric Details
Report Name Bulk Drug Intermediates - Market
CAGR 5%
Segment by Type:
  • GMP
  • Non-GMP
Segment by Application
  • Antibiotics
  • Antipyretic Analgesics
  • Vitamins
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Bulk Drug Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Bulk Drug Intermediates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Bulk Drug Intermediates in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Bulk Drug Intermediates - Market report?

Ans: The main players in the Bulk Drug Intermediates - Market are Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai

What are the Application segmentation covered in the Bulk Drug Intermediates - Market report?

Ans: The Applications covered in the Bulk Drug Intermediates - Market report are Antibiotics, Antipyretic Analgesics, Vitamins, Others

What are the Type segmentation covered in the Bulk Drug Intermediates - Market report?

Ans: The Types covered in the Bulk Drug Intermediates - Market report are GMP, Non-GMP

1 Market Overview
1.1 Bulk Drug Intermediates Product Introduction
1.2 Global Bulk Drug Intermediates Market Size Forecast
1.2.1 Global Bulk Drug Intermediates Sales Value (2019-2030)
1.2.2 Global Bulk Drug Intermediates Sales Volume (2019-2030)
1.2.3 Global Bulk Drug Intermediates Sales Price (2019-2030)
1.3 Bulk Drug Intermediates Market Trends & Drivers
1.3.1 Bulk Drug Intermediates Industry Trends
1.3.2 Bulk Drug Intermediates Market Drivers & Opportunity
1.3.3 Bulk Drug Intermediates Market Challenges
1.3.4 Bulk Drug Intermediates Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bulk Drug Intermediates Players Revenue Ranking (2023)
2.2 Global Bulk Drug Intermediates Revenue by Company (2019-2024)
2.3 Global Bulk Drug Intermediates Players Sales Volume Ranking (2023)
2.4 Global Bulk Drug Intermediates Sales Volume by Company Players (2019-2024)
2.5 Global Bulk Drug Intermediates Average Price by Company (2019-2024)
2.6 Key Manufacturers Bulk Drug Intermediates Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bulk Drug Intermediates Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bulk Drug Intermediates
2.9 Bulk Drug Intermediates Market Competitive Analysis
2.9.1 Bulk Drug Intermediates Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bulk Drug Intermediates Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulk Drug Intermediates as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 GMP
3.1.2 Non-GMP
3.2 Global Bulk Drug Intermediates Sales Value by Type
3.2.1 Global Bulk Drug Intermediates Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bulk Drug Intermediates Sales Value, by Type (2019-2030)
3.2.3 Global Bulk Drug Intermediates Sales Value, by Type (%) (2019-2030)
3.3 Global Bulk Drug Intermediates Sales Volume by Type
3.3.1 Global Bulk Drug Intermediates Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bulk Drug Intermediates Sales Volume, by Type (2019-2030)
3.3.3 Global Bulk Drug Intermediates Sales Volume, by Type (%) (2019-2030)
3.4 Global Bulk Drug Intermediates Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Antibiotics
4.1.2 Antipyretic Analgesics
4.1.3 Vitamins
4.1.4 Others
4.2 Global Bulk Drug Intermediates Sales Value by Application
4.2.1 Global Bulk Drug Intermediates Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bulk Drug Intermediates Sales Value, by Application (2019-2030)
4.2.3 Global Bulk Drug Intermediates Sales Value, by Application (%) (2019-2030)
4.3 Global Bulk Drug Intermediates Sales Volume by Application
4.3.1 Global Bulk Drug Intermediates Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bulk Drug Intermediates Sales Volume, by Application (2019-2030)
4.3.3 Global Bulk Drug Intermediates Sales Volume, by Application (%) (2019-2030)
4.4 Global Bulk Drug Intermediates Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bulk Drug Intermediates Sales Value by Region
5.1.1 Global Bulk Drug Intermediates Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bulk Drug Intermediates Sales Value by Region (2019-2024)
5.1.3 Global Bulk Drug Intermediates Sales Value by Region (2025-2030)
5.1.4 Global Bulk Drug Intermediates Sales Value by Region (%), (2019-2030)
5.2 Global Bulk Drug Intermediates Sales Volume by Region
5.2.1 Global Bulk Drug Intermediates Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bulk Drug Intermediates Sales Volume by Region (2019-2024)
5.2.3 Global Bulk Drug Intermediates Sales Volume by Region (2025-2030)
5.2.4 Global Bulk Drug Intermediates Sales Volume by Region (%), (2019-2030)
5.3 Global Bulk Drug Intermediates Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bulk Drug Intermediates Sales Value, 2019-2030
5.4.2 North America Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bulk Drug Intermediates Sales Value, 2019-2030
5.5.2 Europe Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bulk Drug Intermediates Sales Value, 2019-2030
5.6.2 Asia Pacific Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bulk Drug Intermediates Sales Value, 2019-2030
5.7.2 South America Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bulk Drug Intermediates Sales Value, 2019-2030
5.8.2 Middle East & Africa Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bulk Drug Intermediates Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bulk Drug Intermediates Sales Value
6.2.1 Key Countries/Regions Bulk Drug Intermediates Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bulk Drug Intermediates Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bulk Drug Intermediates Sales Value, 2019-2030
6.3.2 United States Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bulk Drug Intermediates Sales Value, 2019-2030
6.4.2 Europe Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bulk Drug Intermediates Sales Value, 2019-2030
6.5.2 China Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bulk Drug Intermediates Sales Value, 2019-2030
6.6.2 Japan Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bulk Drug Intermediates Sales Value, 2019-2030
6.7.2 South Korea Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bulk Drug Intermediates Sales Value, 2019-2030
6.8.2 Southeast Asia Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bulk Drug Intermediates Sales Value, 2019-2030
6.9.2 India Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bulk Drug Intermediates Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Company Information
7.1.2 Lonza Introduction and Business Overview
7.1.3 Lonza Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Lonza Bulk Drug Intermediates Product Offerings
7.1.5 Lonza Recent Development
7.2 Catalent
7.2.1 Catalent Company Information
7.2.2 Catalent Introduction and Business Overview
7.2.3 Catalent Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Catalent Bulk Drug Intermediates Product Offerings
7.2.5 Catalent Recent Development
7.3 Patheon
7.3.1 Patheon Company Information
7.3.2 Patheon Introduction and Business Overview
7.3.3 Patheon Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Patheon Bulk Drug Intermediates Product Offerings
7.3.5 Patheon Recent Development
7.4 Jubilant
7.4.1 Jubilant Company Information
7.4.2 Jubilant Introduction and Business Overview
7.4.3 Jubilant Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Jubilant Bulk Drug Intermediates Product Offerings
7.4.5 Jubilant Recent Development
7.5 Granules
7.5.1 Granules Company Information
7.5.2 Granules Introduction and Business Overview
7.5.3 Granules Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Granules Bulk Drug Intermediates Product Offerings
7.5.5 Granules Recent Development
7.6 Ganesh
7.6.1 Ganesh Company Information
7.6.2 Ganesh Introduction and Business Overview
7.6.3 Ganesh Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ganesh Bulk Drug Intermediates Product Offerings
7.6.5 Ganesh Recent Development
7.7 Chemcon
7.7.1 Chemcon Company Information
7.7.2 Chemcon Introduction and Business Overview
7.7.3 Chemcon Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Chemcon Bulk Drug Intermediates Product Offerings
7.7.5 Chemcon Recent Development
7.8 BASF
7.8.1 BASF Company Information
7.8.2 BASF Introduction and Business Overview
7.8.3 BASF Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.8.4 BASF Bulk Drug Intermediates Product Offerings
7.8.5 BASF Recent Development
7.9 Porton
7.9.1 Porton Company Information
7.9.2 Porton Introduction and Business Overview
7.9.3 Porton Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Porton Bulk Drug Intermediates Product Offerings
7.9.5 Porton Recent Development
7.10 Lianhetech
7.10.1 Lianhetech Company Information
7.10.2 Lianhetech Introduction and Business Overview
7.10.3 Lianhetech Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Lianhetech Bulk Drug Intermediates Product Offerings
7.10.5 Lianhetech Recent Development
7.11 ABA Chem
7.11.1 ABA Chem Company Information
7.11.2 ABA Chem Introduction and Business Overview
7.11.3 ABA Chem Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.11.4 ABA Chem Bulk Drug Intermediates Product Offerings
7.11.5 ABA Chem Recent Development
7.12 Tianma
7.12.1 Tianma Company Information
7.12.2 Tianma Introduction and Business Overview
7.12.3 Tianma Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Tianma Bulk Drug Intermediates Product Offerings
7.12.5 Tianma Recent Development
7.13 Jiujiujiu
7.13.1 Jiujiujiu Company Information
7.13.2 Jiujiujiu Introduction and Business Overview
7.13.3 Jiujiujiu Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jiujiujiu Bulk Drug Intermediates Product Offerings
7.13.5 Jiujiujiu Recent Development
7.14 Alpha
7.14.1 Alpha Company Information
7.14.2 Alpha Introduction and Business Overview
7.14.3 Alpha Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Alpha Bulk Drug Intermediates Product Offerings
7.14.5 Alpha Recent Development
7.15 Jiuzhou
7.15.1 Jiuzhou Company Information
7.15.2 Jiuzhou Introduction and Business Overview
7.15.3 Jiuzhou Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jiuzhou Bulk Drug Intermediates Product Offerings
7.15.5 Jiuzhou Recent Development
7.16 Yongtai
7.16.1 Yongtai Company Information
7.16.2 Yongtai Introduction and Business Overview
7.16.3 Yongtai Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Yongtai Bulk Drug Intermediates Product Offerings
7.16.5 Yongtai Recent Development
8 Industry Chain Analysis
8.1 Bulk Drug Intermediates Industrial Chain
8.2 Bulk Drug Intermediates Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bulk Drug Intermediates Sales Model
8.5.2 Sales Channel
8.5.3 Bulk Drug Intermediates Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Bulk Drug Intermediates Market Trends
    Table 2. Bulk Drug Intermediates Market Drivers & Opportunity
    Table 3. Bulk Drug Intermediates Market Challenges
    Table 4. Bulk Drug Intermediates Market Restraints
    Table 5. Global Bulk Drug Intermediates Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bulk Drug Intermediates Revenue Market Share by Company (2019-2024)
    Table 7. Global Bulk Drug Intermediates Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Bulk Drug Intermediates Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Bulk Drug Intermediates Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Bulk Drug Intermediates Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Bulk Drug Intermediates Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Bulk Drug Intermediates
    Table 13. Global Bulk Drug Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulk Drug Intermediates as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bulk Drug Intermediates Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Bulk Drug Intermediates Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Bulk Drug Intermediates Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Bulk Drug Intermediates Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Bulk Drug Intermediates Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Bulk Drug Intermediates Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Bulk Drug Intermediates Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Bulk Drug Intermediates Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Bulk Drug Intermediates Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Bulk Drug Intermediates Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Bulk Drug Intermediates Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Bulk Drug Intermediates Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Bulk Drug Intermediates Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Bulk Drug Intermediates Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Bulk Drug Intermediates Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Bulk Drug Intermediates Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Bulk Drug Intermediates Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Bulk Drug Intermediates Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Bulk Drug Intermediates Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Bulk Drug Intermediates Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Bulk Drug Intermediates Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Bulk Drug Intermediates Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Bulk Drug Intermediates Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Bulk Drug Intermediates Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Bulk Drug Intermediates Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Bulk Drug Intermediates Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Bulk Drug Intermediates Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Bulk Drug Intermediates Sales Value by Region (2019-2024) & (%)
    Table 44. Global Bulk Drug Intermediates Sales Value by Region (2025-2030) & (%)
    Table 45. Global Bulk Drug Intermediates Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Bulk Drug Intermediates Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Bulk Drug Intermediates Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Bulk Drug Intermediates Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Bulk Drug Intermediates Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Bulk Drug Intermediates Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Bulk Drug Intermediates Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Bulk Drug Intermediates Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Bulk Drug Intermediates Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Bulk Drug Intermediates Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Bulk Drug Intermediates Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Bulk Drug Intermediates Sales Volume, (2025-2030) & (K Units)
    Table 57. Lonza Company Information
    Table 58. Lonza Introduction and Business Overview
    Table 59. Lonza Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Lonza Bulk Drug Intermediates Product Offerings
    Table 61. Lonza Recent Development
    Table 62. Catalent Company Information
    Table 63. Catalent Introduction and Business Overview
    Table 64. Catalent Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Catalent Bulk Drug Intermediates Product Offerings
    Table 66. Catalent Recent Development
    Table 67. Patheon Company Information
    Table 68. Patheon Introduction and Business Overview
    Table 69. Patheon Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Patheon Bulk Drug Intermediates Product Offerings
    Table 71. Patheon Recent Development
    Table 72. Jubilant Company Information
    Table 73. Jubilant Introduction and Business Overview
    Table 74. Jubilant Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Jubilant Bulk Drug Intermediates Product Offerings
    Table 76. Jubilant Recent Development
    Table 77. Granules Company Information
    Table 78. Granules Introduction and Business Overview
    Table 79. Granules Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Granules Bulk Drug Intermediates Product Offerings
    Table 81. Granules Recent Development
    Table 82. Ganesh Company Information
    Table 83. Ganesh Introduction and Business Overview
    Table 84. Ganesh Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Ganesh Bulk Drug Intermediates Product Offerings
    Table 86. Ganesh Recent Development
    Table 87. Chemcon Company Information
    Table 88. Chemcon Introduction and Business Overview
    Table 89. Chemcon Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Chemcon Bulk Drug Intermediates Product Offerings
    Table 91. Chemcon Recent Development
    Table 92. BASF Company Information
    Table 93. BASF Introduction and Business Overview
    Table 94. BASF Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. BASF Bulk Drug Intermediates Product Offerings
    Table 96. BASF Recent Development
    Table 97. Porton Company Information
    Table 98. Porton Introduction and Business Overview
    Table 99. Porton Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Porton Bulk Drug Intermediates Product Offerings
    Table 101. Porton Recent Development
    Table 102. Lianhetech Company Information
    Table 103. Lianhetech Introduction and Business Overview
    Table 104. Lianhetech Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Lianhetech Bulk Drug Intermediates Product Offerings
    Table 106. Lianhetech Recent Development
    Table 107. ABA Chem Company Information
    Table 108. ABA Chem Introduction and Business Overview
    Table 109. ABA Chem Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. ABA Chem Bulk Drug Intermediates Product Offerings
    Table 111. ABA Chem Recent Development
    Table 112. Tianma Company Information
    Table 113. Tianma Introduction and Business Overview
    Table 114. Tianma Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Tianma Bulk Drug Intermediates Product Offerings
    Table 116. Tianma Recent Development
    Table 117. Jiujiujiu Company Information
    Table 118. Jiujiujiu Introduction and Business Overview
    Table 119. Jiujiujiu Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Jiujiujiu Bulk Drug Intermediates Product Offerings
    Table 121. Jiujiujiu Recent Development
    Table 122. Alpha Company Information
    Table 123. Alpha Introduction and Business Overview
    Table 124. Alpha Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Alpha Bulk Drug Intermediates Product Offerings
    Table 126. Alpha Recent Development
    Table 127. Jiuzhou Company Information
    Table 128. Jiuzhou Introduction and Business Overview
    Table 129. Jiuzhou Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Jiuzhou Bulk Drug Intermediates Product Offerings
    Table 131. Jiuzhou Recent Development
    Table 132. Yongtai Company Information
    Table 133. Yongtai Introduction and Business Overview
    Table 134. Yongtai Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Yongtai Bulk Drug Intermediates Product Offerings
    Table 136. Yongtai Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Bulk Drug Intermediates Downstream Customers
    Table 140. Bulk Drug Intermediates Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bulk Drug Intermediates Product Picture
    Figure 2. Global Bulk Drug Intermediates Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bulk Drug Intermediates Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Bulk Drug Intermediates Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Bulk Drug Intermediates Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Bulk Drug Intermediates Report Years Considered
    Figure 7. Global Bulk Drug Intermediates Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Bulk Drug Intermediates Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bulk Drug Intermediates Revenue in 2023
    Figure 10. Bulk Drug Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. GMP Picture
    Figure 12. Non-GMP Picture
    Figure 13. Global Bulk Drug Intermediates Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Bulk Drug Intermediates Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Bulk Drug Intermediates Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Bulk Drug Intermediates Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Bulk Drug Intermediates Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Antibiotics
    Figure 19. Product Picture of Antipyretic Analgesics
    Figure 20. Product Picture of Vitamins
    Figure 21. Product Picture of Others
    Figure 22. Global Bulk Drug Intermediates Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Bulk Drug Intermediates Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Bulk Drug Intermediates Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Bulk Drug Intermediates Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Bulk Drug Intermediates Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Bulk Drug Intermediates Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Bulk Drug Intermediates Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Bulk Drug Intermediates Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Bulk Drug Intermediates Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Bulk Drug Intermediates Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Bulk Drug Intermediates Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Bulk Drug Intermediates Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Bulk Drug Intermediates Sales Volume (%), (2019-2030)
    Figure 39. United States Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Bulk Drug Intermediates Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Bulk Drug Intermediates Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Bulk Drug Intermediates Sales Value by Application (%), 2023 VS 2030
    Figure 60. Bulk Drug Intermediates Industrial Chain
    Figure 61. Bulk Drug Intermediates Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Z18292
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14Z15017
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7M18883
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37J14968
Thu Dec 12 00:00:00 UTC 2024

Add to Cart